Through heightened awareness and education on skin disorders in Parkinson disease (PD), neurologists and dermatologists can better recognize PD-related manifestations that are present on the skin and direct patients to the optimal source of care for these issues.
Through heightened awareness and education on skin disorders in Parkinson disease (PD), neurologists and dermatologists can better recognize skin-related manifestations of PD and direct patients to the optimal source of care for these issues, said Nicki Niemann, MD, neurologist at the Muhammad Ali Parkinson Center and an assistant professor of neurology at Barrow Neurological Institute.
Transcript
AJMC®: Hello, I'm Matthew Gavidia. Today on the MJH Life Sciences™ Medical World News, The American Journal of Managed Care® is pleased to welcome Dr Nicki Niemann, neurologist at the Muhammad Ali Parkinson Center and an assistant professor of neurology at Barrow Neurological Institute. Dr Niemann additionally served as a co-author of a review article titled “Parkinson disease and skin.”
In the review, it was noted that the presence of particular skin disorders may predate onset of motor symptoms in PD. Can you further discuss this trend, especially when it comes to potential diagnostic implications?
Niemann: I think I may have alluded to that a little bit before. To the best of my knowledge, and according to the best available evidence, the primary skin disorders that seem to come up sometime before PD is recognized would be sweating changes or changes in sweat pattern and seborrheic dermatitis–probably, as I mentioned before, because both are influenced by dysfunction of the autonomic nervous system.
Then the other conditions that seem to occur later on would be things like melanoma and bullous pemphigoid. I think the main takeaway is that neurologists should be aware that that patients with PD can have symptoms that don't neatly fall into a box with neurological symptoms and signs, and need to be able to make an association between something like PD and a specific skin disorder—not necessarily so they can treat it, but at least a way that they can direct the patient to a provider that would be able to help such as a dermatologist.
On the other hand, it's equally important that a dermatologist understands that certain conditions—in this case, bullous pemphigoid comes to mind—certain conditions in dermatology can have a very high rate of neurological comorbidities. They may already have been recognized, but in other cases, neurological comorbidities may be present, but unrecognized. And I think this would be something that should be discovered or uncovered just by the record of review systems. Although sometimes, it can be tricky to do in a busy clinical practice.
AJMC®: How can neurologists and dermatologists better assess skin-related manifestations of PD?
Niemann: Yeah, I think the great and obvious thing about skin is that it's almost impossible not to be inspected during a routine visit when we’re with the patient. It doesn't matter if that's with the internist, surgeon, or the neurologist, but going back to the prior discussion, I think more education about skin disorders in PD is what is needed to help raise awareness, and will kind of help us see what is in plain sight. If we start to look for these things, I think we'll pick up on them better, and we'll start to make an association with PD, which might not previously have been the case.
AJMC®: Lastly, do you have any other concluding thoughts?
Niemann: Yeah, well, first of all, thank you for inviting me to speak with you about our article. I hope this discussion helps raise awareness about skin disorders in PD, and I’d also like to mention that even though we didn't really discuss it at length, because it wasn't the topic of primary focus of the paper, I think skin is going to play a central role going forward in PD—not just in diagnostics, like I've mentioned before, but also potentially therapeutics.
We know that skin can be used to generate stem cells. Stem cells can be used both to test drugs, but can also be used directly as novel stem cell-based therapies. We're not quite there yet, but I think there's a lot of promise and a lot of exciting science going on.
AJMC®: To learn more, visit our website at AJMC.com. I’m Matthew Gavidia, thanks for joining us!
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More